Navigation Links
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
Date:11/14/2007

s. Lilly has implemented a risk management program that includes comprehensive measures regarding the appropriate use of FORTEO in the target patient population. A Medication Guide explaining the details of the drug to the patient also accompanies the product. FORTEO also has a "boxed warning" in its package insert about the osteosarcoma findings in rats during preclinical testing. For full prescribing information, please visit http://www.FORTEO.com.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.

P-LLY

Forward Looking Statement

This press release contains forward-looking statements about the safety and efficacy of FORTEO and reflects Lilly's current beliefs. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that FORTEO will continue to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

(1) N Engl J Med. 2007; TBD

(2) 2 Trends in Endo. And Meta. 2006;17(4); 144-149.

(3) Clin Rheumatol. 2007; 26: 144-153.

(4) Endocrinol Metab Clin N Am. 2003; 32; 135-157.

(5) N Engl J Med. 2001; 344: 1434-1441.

(6) Prescribing information for FORTEO.

(7) Draft prescr
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Seriously Low Vaccination Rates Cause Experts to Call for Increased Immunization Before Influenza Season Peaks
2. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
3. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
4. Superbug Outbreak Calls for Immediate Increased Attention on Infection Control
5. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
6. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
7. Syndicom SpineConnect Web Platform Chosen for Applied Spines Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System
8. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014  Columbia Laboratories, Inc. (Nasdaq: ... of pharmaceutical development, clinical trial manufacturing, and advanced analytical ... that it will participate at the upcoming Rodman & ... be held in New York . ... on September 9, 2014 at the New York Palace ...
(Date:8/27/2014)... and NINGBO, China , Aug. ... Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") today announced they ... of generic pharmaceuticals, primarily targeting the United ... agreement, Amerigen and Menovo will jointly develop products for ... . Menovo will be responsible for manufacturing API ...
(Date:8/27/2014)... Aug. 27, 2014 /CNW/ - Covalon Technologies Ltd. (the "Company" ... the following financial results for its third quarter of fiscal ... 2014: , Revenue of $1,291,378, a 13% decrease ... Net loss for the quarter of $240,156 compared to net ... year For the nine months ended June ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... from Biodel Inc. (Nasdaq: BIOD ) reported ... basal insulin and stabilized glucagon development programs in poster ... Technology Meeting in Bethesda, MD.   Dr. ... double-blind, randomized crossover trial in 13 subjects with type ...
... (NYSE Amex: NBS ) ("NeoStem" or the ... revenues, global research and development capabilities and operations in ... adult stem cells, and China pharmaceuticals, is today providing ... Third Quarter Results Revenues for the nine ...
Cached Medicine Technology:Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 2Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 3Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 4Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 5NeoStem Provides Third Quarter Update 2NeoStem Provides Third Quarter Update 3
(Date:8/27/2014)... Connor Sports has produced six ... in Spain at the Barcelona, Bilbao, Gran Canaria, Granada, ... & Venue Centre Partner since 1994 and Official Technical Supplier ... will bear the Connor Sports logo and tagline “Where Champions ... the ESPN broadcasts of the FIBA World Cup. , “Connor ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 When Jagger was ... call from his mother; one that he credits as one ... His mom had news that she could set him up ... people with disabilities. Jagger took that job, and he has ... Throughout these past two decades, he also worked in school ...
(Date:8/27/2014)... News) -- Overconfident people are better at convincing others ... therefore are more likely to get promotions and reach ... added that these "self-deceived" people are also more likely ... risks. And finally, people who underestimate themselves are ... the British researchers. Their findings were published Aug. 27 ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 CarePoint ... pediatric practice, Hoboken Pediatrics has joined our network, ... Andrzej Klos, Dr. Piotr Oko, Dr. Yanina Meshko ... of highly skilled and experienced physicians comprise CarePoint ... doctors and practices in Hudson County, representing a ...
(Date:8/27/2014)... Georgia State University’s Center for Leadership in ... from the Maternal and Child Health Bureau of ... implementation of the Autism Plan for Georgia, aimed ... autism spectrum disorder. , In preparing for this ... composed of key stakeholders from across Georgia. The ...
Breaking Medicine News(10 mins):Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 3Health News:Center for Leadership in Disability Awarded $600,000 Grant to Improve Services for Georgia’s Children and Youth with Autism 2
... by Suresh Alahari, PhD, Associate Professor of Biochemistry and Molecular ... for the first time that a tiny piece of RNA ... invasive breast cancer and identified a gene that appears to ... August 21, 2009 issue of the Journal of Biological ...
... New test could lead to clearer glass for hand-held ... touch screens of BlackBerrys and iPhones tend to smudge ... determine the chemical composition and the effectiveness of protective ... of better anti-smudge, anti-reflective coverings. , The key to ...
... at an all-time low, new government report shows, , WEDNESDAY, ... States has reached almost 78 years, a record high, federal ... increased, but the death rate has dropped to an all-time ... new report from the U.S. Centers for Disease Control and ...
... the biggest challenges in scientists, quest to develop new and ... how and why cancer spreads. Recent breakthroughs have uncovered ... the molecular level, but much remains to be understood about ... developed by Klaus Hahn, Ph.D. and his colleagues uses light ...
... WASHINGTON, Aug. 19 The following is a statement ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) , ... today that it is establishing the Center for Tobacco Products and ... public health leader, as the Center Director is a demonstration of ...
... ... , ... 2009 -- Scientists from the U.S. Department of Energy,s (DOE) Argonne National Laboratory ... cancer cells using inorganic titanium dioxide nanoparticles bonded to soft biological material., , , , ...
Cached Medicine News:Health News:LSUHSC research discovers new targets for treatment of invasive breast cancer 2Health News:A Smudge-Free Smart Phone Screen? 2Health News:Life Expectancy in U.S. Hits a New High 2Health News:Life Expectancy in U.S. Hits a New High 3Health News:Tobacco-Free Kids Welcomes Formation of FDA's Center for Tobacco Products and Selection of Center Director 2Health News:Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials 2Health News:Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials 3
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
A unique system for secure fixation of the cranial bone flap after craniotomy. Craniofix eliminates the need for mini plates, screws, and additional drills....
1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery....
... Cable System, designed for ... sublaminar interspinous fixation, non-displaced ... sternotomy closure. Consists of ... complete set of instruments ...
Medicine Products: